Clinical Trial Update: Serum Neurofilaments and GFAP in Atypical Multiple Sclerosis [NA]

View source ↗

Summary

This clinical trial update reports measurements of serum neurofilaments and GFAP in patients with relapsing-remitting and progressive multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Progressive Multiple Sclerosis
• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: University Hospital, Montpellier | Conditions: Relapsing Remitting Multiple Sclerosis, Progressive Multiple Sclerosis | NA | Status: COMPLETED